Oregon Translational Research Anddrug Development Institute
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 1,415,138 | 1,422,369 | −7,231 | 29.1 | 39% |
| 2012 | 1,480,323 | 1,417,434 | 62,889 | 29.7 | 36% |
| 2013 | 1,474,554 | 1,907,660 | −433,106 | 19.4 | 22% |
| 2014 | 1,487,796 | 1,513,385 | −25,589 | 24.2 | 26% |
| 2015 | 1,441,429 | 1,899,105 | −457,676 | 16.8 | 26% |
| 2016 | 1,882,803 | 1,939,225 | −56,422 | 16.1 | 27% |
| 2017 | 1,616,831 | 1,599,697 | 17,134 | 19.6 | 25% |
| 2018 | 1,804,620 | 1,589,775 | 214,845 | 21.4 | 24% |
| 2019 | 1,920,057 | 1,609,790 | 310,267 | 23.4 | 23% |
| 2020 | 1,824,854 | 1,524,119 | 300,735 | 27.1 | 24% |
| 2021 | 2,041,535 | 1,724,569 | 316,966 | 26.2 | 27% |
| 2022 | 2,222,628 | 2,017,841 | 204,787 | 23.6 | 26% |
| 2023 | 1,827,560 | 2,038,542 | −210,982 | 25.6 | 22% |
In its most recent public year (2023), this organization spent $210,982 more than it brought in. Its reserves stood at about 25.6 months of spending, down from 29.1 in 2011. Staff pay was 22% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Oregon Translational Research Anddrug Development Institute's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works